Zhang You, Wu Yuqi, Pan Dan, Zhang Zhenyu, Jiang Lu, Feng Xiaodong, Jiang Yuchen, Luo Xiaobo, Chen Qianming
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Front Surg. 2023 Jan 6;9:1068256. doi: 10.3389/fsurg.2022.1068256. eCollection 2022.
Oral potentially malignant disorders (OPMDs) are a spectrum of diseases that harbor the potential of malignant transformation and developing into oral squamous cell carcinoma (OSCC). Narrow band imaging (NBI) has been clinically utilized for the adjuvant diagnosis of OPMD and OSCC. This study aimed to comprehensively evaluate the diagnostic accuracy of NBI for malignant transformations of OPMD by applying the intraepithelial papillary capillary loop (IPCL) classification approach.
Studies reporting the diagnostic validity of NBI in the detection of OPMD/OSCC were selected. Four databases were searched and 11 articles were included in the meta-analysis. We performed four subgroup analyses by defining IPCL I/II as negative diagnostic results and no/mild dysplasia as negative pathological outcome. Pooled data were analyzed using random-effects models. Meta-regression analysis was performed to explore heterogeneity.
After pooled analysis of the four subgroups, we found that subgroup 1, defining IPCL II and above as a clinically positive result, demonstrated the most optimal overall diagnostic accuracy for the malignant transformation of OPMDs, with a sensitivity and specificity of NBI of 0.87 (95% confidence interval (CI) [0.67, 0.96], < 0.001) and 0.83 [95% CI (0.56, 0.95), < 0.001], respectively; while the other 3 subgroups displayed relatively low sensitivity or specificity.
NBI is a promising and non-invasive adjunctive tool for identifying malignant transformations of OPMDs. The IPCL grading is currently a sound criterion for the clinical application of NBI. After excluding potentially false positive results, these oral lesions classified as IPCL II or above are suggested to undergo biopsy for early and accurate diagnosis as well as management.
口腔潜在恶性疾病(OPMDs)是一系列具有恶性转化潜力并发展为口腔鳞状细胞癌(OSCC)的疾病。窄带成像(NBI)已在临床上用于OPMD和OSCC的辅助诊断。本研究旨在通过应用上皮内乳头毛细血管袢(IPCL)分类方法全面评估NBI对OPMD恶性转化的诊断准确性。
选择报告NBI在检测OPMD/OSCC中诊断有效性的研究。检索了四个数据库,11篇文章纳入荟萃分析。我们通过将IPCL I/II定义为阴性诊断结果,将无/轻度发育异常定义为阴性病理结果进行了四项亚组分析。使用随机效应模型分析汇总数据。进行荟萃回归分析以探索异质性。
对四个亚组进行汇总分析后,我们发现亚组1将IPCL II及以上定义为临床阳性结果,对OPMDs的恶性转化显示出最佳的总体诊断准确性,NBI的敏感性和特异性分别为0.87(95%置信区间[CI][0.67, 0.96],<0.001)和0.83 [95% CI(0.56, 0.95),<0.001];而其他3个亚组显示出相对较低的敏感性或特异性。
NBI是一种有前景的非侵入性辅助工具,用于识别OPMDs的恶性转化。IPCL分级目前是NBI临床应用的可靠标准。在排除潜在的假阳性结果后,建议对这些分类为IPCL II或以上的口腔病变进行活检,以进行早期准确诊断和管理。